Clinical Trial Update: A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154 [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating subcutaneous ABBV-154 for Polymyalgia Rheumatica was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• ABBV-154

Snippet

Sponsor: AbbVie | Conditions: Polymyalgia Rheumatica | Phase 2 | Status: TERMINATED | Results posted: 2024-10-15